๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
SRS/SRT/Hypo-RT Versus HA-WBRT for No More Than 10 Brain Metastases in SCLC
NCT06457906Small-cell Lung Cancer, Brain Metastases, SRS, Stereotactic Radiotherapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
340
Beijing
2023-09-01
Recruiting
Perioperative Sintilimab Plus Bevacizumab Biosimilar and TACE-HAIC for HCC Patients With PVTT: A Phase-2 Clinical Trial
NCT06031285Hepatocellular Carcinoma
Sun Yat-sen University
Phase 2
43
Guangzhou
2023-09-01
Recruiting
Lenvatinib, Tislelizumab Combined with Gemcitabine and Cisplatin (GPLET) in the Treatment of Advanced Cholangiocarcinoma
NCT05823311Advanced Cholangiocarcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 3
80
Hangzhou
2023-09-01
Recruiting
Exploring of Serum Biomarkers of Delirium After Cardiovascular Surgery
NCT06007755Delirium
Huazhong University of Science and Technology
Observational
113
Wuhan
2023-09-01
Not yet open
Effectiveness of Ketogenic Diet in MELAS Syndrome
NCT06013397MELAS Syndrome, Ketogenic Dieting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
100
Hangzhou
2023-09-01
Not yet open
Efficacy and Safety of Disitamab Vedotin Plus Pyrotinib or Naratinib in HER2-positive Breast Cancer Patients With Brain Metastasis
NCT06015113Breast Cancer
Xi'an International Medical Center Hospital
Not applicable
20
Xi'an
2023-09
Not yet open
Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation
NCT06041490Liver Transplant; Complications, Hepatocarcinoma, Recurrent Osteosarcoma, High-Risk Cancer
Peking Union Medical College Hospital
Phase 2
88
Beijing
2023-09
Active, closed
Fraction Dose Escalation of Split-course Hypofractionated Concurrent Chemoradiotherapy Following Induction Chemo-immunotherapy in Unresectable Locally Advanced Esophageal Squamous Carcinoma: a Phase I Study.
NCT06020885Esophageal Squamous Cell Carcinoma
Sun Yat-sen University
Phase 1
18
Guangzhou
2023-08-31
Active, closed
A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC
NCT05884398Metastatic Castrate-sensitive Prostate Cancer
Janssen Research & Development, LLC
Phase 3
420
Beijing, Changchun, Chengdu, Guangzhou, Jinan, Ningbo, Shenyang, Wuhan
2023-08-31
Recruiting
Construction of A Multimodal Digital Assessment Model for Myasthenia Gravis
NCT07146425Myasthenia Gravis
Huashan Hospital
Observational
180
Shanghai
2023-08-31
Recruiting
An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease
NCT05908695Alzheimer's Disease
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
Phase 4
1,312
Huainan, Beijing, Xiamen, Guangzhou, Shenzhen, Nanning, Shijiazhuang, Tangshan
2023-08-31
Recruiting
The Effects of Anesthetics on Brain Network Connectivity in Patients With Supratentorial Glioma
NCT06138340Brain Network Connectivity, Postoperative Delirium, Dexmedetomidine, Propofol
Beijing Tiantan Hospital
Observational
120
Beijing
2023-08-31
Active, closed
A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)
NCT06081894Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
Cytokinetics
Phase 3
500
Guangzhou, Beijing, Jilin City, Nanjin, Shanghai, Shenyang, Wuhan, Xi'an
2023-08-31
Recruiting
The Effects of Ferric Derisomaltose on Postoperative Anemia in Spinal Deformity Surgery
NCT05714007Perioperative Anemia, Surgery, Spinal Deformity, Adult
Peking Union Medical College Hospital
Phase 4
120
Beijing
2023-08-31
Recruiting
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
NCT06051409Ph+ ALL, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
Ascentage Pharma Group Inc.
Phase 3
350
Bengbu, Chongqing, Guangdong, Zhengzhou, Wuhan, Suzhou, Shanghai, Chengdu
2023-08-31
Recruiting
Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment
NCT06534489Non-small Cell Lung Cancer, Surgery
Ruijin Hospital
Observational
50
Shanghai
2023-08-31
Not yet open
Efficacy and Safety of Carrimycin Tablets in HLH Patients With Carbapenem-resistant Infections
NCT05988177Carbapenem Resistant Bacterial Infection, Hemophagocytic Lymphohistiocytoses
Beijing Friendship Hospital
Not applicable
20
Beijing
2023-08-30
Recruiting
TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT
NCT05984511Hepatocellular Carcinoma, Hepatic Portal Vein Tumor Invasion, Tumor Thrombus
Third Affiliated Hospital, Sun Yat-Sen University
Not applicable
234
Guangzhou
2023-08-30
Active, closed
The Efficacy and Safety of EOB-MRI Guided Microwave Ablation for Early HCC: A Multicenter, Prospective, Observational Study
NCT06096896Early Hepatocellular Carcinoma
Shandong Provincial Hospital
Observational
334
Jinan
2023-08-30
Recruiting
The Evaluation of the Effectiveness and Safety of Nalbuphine Hydrochloride Injection for Analgesia in ICU Patients: A Multicenter, Randomized, Single-blinded, Parallel, Two-step Trial
NCT06785571Respiratory Insufficiency
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2/3
204
Wuhan
2023-08-30
Recruiting
Digital Cognitive Behavioral Therapy for Insomnia for Chronic Insomnia in Breast Cancer Survivors
NCT05813392Chronic Insomnia
Peking University First Hospital
Not applicable
264
Beijing
2023-08-29
Recruiting
Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models
NCT06002425Gastrointestinal Neoplasm Malignant
Chinese Academy of Sciences
Not applicable
400
Jiangmen, Zhuhai, Hohhot
2023-08-29
Active, closed
Phase I/II FIH Study of 9MW2921 in Patients With Advanced Solid Tumors
NCT05990452Advanced Solid Tumor
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1/2
261
Shanghai
2023-08-28
Recruiting
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
NCT06126224Psychosis Associated With Alzheimer's Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
500
Hefei, Beijing, Chongqing, Guangzhou, Shenzhen, Nanjing, Nanchang, Shanghai
2023-08-28
Recruiting
A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune Thrombocytopenia
NCT05995054Immune Thrombocytopenia, Treatment
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
110
Tianjin
2023-08-28
Recruiting
Drug-eluting Stenting Versus Medical Treatment for Extracranial Vertebral Artery Stenosis
NCT05885932Ischemic Stroke, Vertebral Artery Stenosis
Xuanwu Hospital, Beijing
Not applicable
472
Beijing
2023-08-25
Recruiting
Risk Stratification Value of Biomarkers in Patients With Myocarditis
NCT06010199Myocarditis
First Affiliated Hospital Xi'an Jiaotong University
Observational
1,000
Xi'an
2023-08-25
Recruiting
A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Chinese Participants With Diffuse Large B-Cell Lymphoma
NCT05954910Diffuse Large B-Cell Lymphoma
Hoffmann-La Roche
Observational
1,000
Beijing, Changchun, Changsha, Chengdu, Guangzhou, Guiyang, Haikou, Hohhot
2023-08-25
Recruiting
AK104 for Recurrent or Metastatic Vulvar Cancer
NCT05932212Vulvar Cancer
Akeso
Phase 2
20
Fuzhou, Guangzhou, Shijiangzhuang, Shenyang, Tianjin, Hangzhou
2023-08-25
Recruiting
Artificial Intelligence (AI) Analysis of Synchronized Phonocardiography (PCG) and Electrocardiogram(ECG)
NCT06009718Heart Failure
Ruijin Hospital
Observational
3,000
Shanghai
2023-08-25
Recruiting
A Study of WX390 Combined With Toripalimab in Patients With Advanced Gastric-type Endocervical Adenocarcinoma With STK11 Mutations
NCT06124963Gastric Type Adenocarcinoma (GAS) With STK11 Mutation
Shanghai Jiatan Pharmatech Co., Ltd
Phase 2
20
Shanghai
2023-08-25
Recruiting
The Efficacy of Salvage Surgery in Patients With Residual Tumor After Concurrent Chemoradiation for Locally Advanced Cervical Cancer.
NCT05749887Cervical Cancer
Chongqing University Cancer Hospital
Not applicable
188
Chongqing
2023-08-25
Active, closed
Safety, Tolerability, Pharmacokinetics and Immunogenicity Study of GB002 Recombinant Peptide Inhalation Solution in Healthy Subjects
NCT06423261Healthy
Zhejiang Echon Biopharm Limited
Phase 1
100
Changsha
2023-08-24
Recruiting
Low-Dose Involved-Field Radiotherapy Plus Immunochemotherapy for ESCC
NCT06603402Esophageal Squamous Cell Carcinoma (ESCC), Immunotherapy
Sichuan University
Phase 2
41
Chengdu
2023-08-24
Recruiting
Lactobacillus Vaginalis Capsules for Treatment of Vulvovaginal Atrophy in Young Breast Cancer Patients
NCT05974449Breast Cancer Female
The First Affiliated Hospital with Nanjing Medical University
Phase 2
60
Nanjing
2023-08-24
Recruiting
Cetuximab Plus Irinotecan in Patients With NeoRAS Wild-type Metastatic Colorectal Cancer In Third-line Therapy
NCT05962502Metastatic Colorectal Cancer
Sun Yat-sen University
Phase 2
54
Guangzhou
2023-08-24
Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
NCT06023589Asthma
AstraZeneca
Phase 3
231
Beijing, Changchun, Hohhot, Lanzhou, Nanjing, Shanghai, Shenyang, Shenzhen
2023-08-24
Recruiting
Safety and Efficacy of Anti-CD20/CD30 CAR-T Cells in Subjects with Relapsed/Refractory Lymphoma
NCT06532643Relapsed/Refractory Lymphoma
Shanghai First Song Biotechnology Co., LTD
Phase EARLY_PHASE1
9
Hefei
2023-08-24
Recruiting
pBFS-guided cTBS Over the Inferior Frontal Gyrus for Aphasia After Ischemic Stroke
NCT05907031Stroke, Ischemic, Aphasia
Changping Laboratory
Not applicable
30
Fuzhou
2023-08-23
Recruiting
Personalized Optimization of Systematic Prostate Biopsy
NCT05998278Prostate Adenocarcinoma
Fujian Medical University Union Hospital
Not applicable
330
Fuzhou
2023-08-23
Recruiting
Balloon angiopLasty for Intracranial Atherosclerotic Minor Stroke/TIA
NCT06014723Ischemic Stroke
Shouchun Wang, MD, PhD
Observational
416
Changchun
2023-08-23
Recruiting
Intervention of Nicotinamide Mononucleotide in Middle-aged and Elderly People
NCT06592859Aging, NMN
People's Hospital of Quzhou
Not applicable
240
Quzhou
2023-08-23
Recruiting
A Dose Escalation and Dose Expansion Clinical Study of STI-7349 in Subjects With Advanced Solid Tumors
NCT05978102Advanced Solid Tumor
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Phase 1/2
183
Yiwu
2023-08-23
Active, closed
Cadonilimab (AK104) Plus Lenvatinib in Previously Immunotherapy-Treated Advanced/Metastatic Clear Cell Renal Cell Carcinoma
NCT06035224Clear Cell Renal Cell Carcinoma
RenJi Hospital
Phase 2
28
Shanghai
2023-08-23
Recruiting
Maintenance Tislelizumab + Capecitabine to Treat Metastatic Colorectal Cancer
NCT05360277Metastatic Colorectal Cancer๏ผŒNED
Yanhong Deng
Phase 2
52
Guangzhou
2023-08-22
Recruiting
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
NCT05995964Atopic Dermatitis
Pfizer
Phase 2
340
Beijing, Fuzhou, Dongguan, Guangzhou, Shijiazhuang, Changsha, Wuhan, Zhenjiang
2023-08-22
Recruiting
Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer
NCT06039631Larynx Cancer, Hypopharyngeal Cancer
Fudan University
Phase 2
82
Shanghai
2023-08-22
Active, closed
Investigate the Efficacy and Safety of BRII-835 (VIR-2218) and PEG-IFNฮฑ Combination Therapy in Chronic HBV Patients
NCT05970289Chronic Hepatitis B Virus Infection
Brii Biosciences Limited
Phase 2
86
Beijing, Chongqing, Guangzhou, Hong Kong, Changchun, Shanghai, Kaohsiung, Taipei
2023-08-22
Recruiting
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CYH33 in Patients With PIK3CA-related Overgrowth Spectrum (PROS) and PIK3CA-related Vascular Malformations (PRVM)
NCT06975618PIK3CA-Related Overgrowth Spectrum (PROS), PIK3CA-related Vascular Malformations (PRVM)
Haihe Biopharma Co., Ltd.
Phase 1/2
141
Beijing, Fuzhou, Guangzhou, Zhengzhou, Changsha, Shanghai, Chengdu
2023-08-22
Recruiting
OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
NCT06355934ATTR Amyloidosis
AstraZeneca
Observational
52,121
Beijing, Changsha, Chengdu, Guangzhou, Wuhan
2023-08-21
Active, closed
Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis
NCT06174402Primary Biliary Cholangitis
Han Ying
Phase 2/3
184
Lanzhou, Guangzhou, Nanjing, Shenyang, Xi'an, Yanโ€™an, Kunming, Beijing
2023-08-21
Recruiting
A Phase 3 Clinical Study of QLM3004 in Delaying Myopia in Children
NCT06151587Myopia
Qilu Pharmaceutical Co., Ltd.
Phase 3
735
Wenzhou
2023-08-20
Recruiting
Maximal Tumor Eradication for Oligometastatic Prostate Cancer
NCT06972511Oligometastatic Prostate Cancer
RenJi Hospital
Phase 2/3
120
Shanghai
2023-08-20
Recruiting
An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus
NCT06010472Systemic Lupus Erythematosus (SLE)
Changhai Hospital
Phase EARLY_PHASE1
36
Shanghai
2023-08-20
Recruiting
A Prospective Cohort Study of Myasthenia Gravis in China
NCT06006832Myasthenia Gravis
Peking Union Medical College Hospital
Observational
202
Beijing
2023-08-20
Recruiting
A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)
NCT05999149TNBC - Triple-Negative Breast Cancer
Fudan University
Phase 3
424
Shanghai
2023-08-20
Recruiting
Precision Radiotherapy for Tumours Using Magnetic Resonance-guided Linear Accelerator (MR-Linac)
NCT06531681Overall Response Rate, Oncology, Radiation Toxicity, Quality of Life
The Second Affiliated Hospital of Hainan Medical University
Observational
3,000
Haikou
2023-08-19
Recruiting
The Combination of Adebrelimab and TP Regimen for Neoadjuvant Therapy in Patients With Stage IVB Oral Squamous Cell Carcinoma
NCT06277791Clinical IVb Stage Oral Squamous Cell Carcinomas Patients
Hospital of Stomatology, Wuhan University
Phase 2
35
Hubei
2023-08-19
Recruiting
Sintilimab Combined With Chemotherapy and Radiotherapy in Patients With Inoperable Pancreatic Cancer
NCT06050317Pancreas Cancer
Shandong Cancer Hospital and Institute
Phase 2
25
Jinan
2023-08-18
Recruiting
Lorlatinib as the First-line Treatment in China Advanced ALK+ NSCLC
NCT06092086ALK Positive Non-small Cell Lung Cancer
Guangdong Association of Clinical Trials
Phase 2
126
Guangzhou
2023-08-18
Recruiting
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
NCT05875168Advanced Solid Tumor, Metastatic Solid Tumor
Daiichi Sankyo
Phase 1/2
590
Beijing, Jinan, Neijiang, Shanghai
2023-08-18
Recruiting
RY_SW01 Cell Injection Therapy in Active Lupus Nephritis
NCT06058078Lupus Nephritis
Jiangsu Renocell Biotech Company
Phase 2
60
Nanjing
2023-08-17
Recruiting
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
NCT05914116Advanced Solid Tumors
DualityBio Inc.
Phase 1/2
862
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Nanning, Baoding, Harbin
2023-08-17
Recruiting
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
NCT05785741Advanced Solid Tumor
DualityBio Inc.
Phase 1/2
1,000
Zhengzhou, Changsha, Nanjing, Wuxi, Changchun, Shenyang, Shanghai, Chengdu
2023-08-17
Recruiting
TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases
NCT05948813NSCLC, EGFR Activating Mutation, Brain Metastases
TYK Medicines, Inc
Phase 2
420
Beijing
2023-08-17
Recruiting
Pyrotinib Combined With Trastuzumab and Chemotherapy Neoadjuvant Therapy for HER2-positive Breast Cancer
NCT06035679Breast Cancer Female
Youzhi Zhu
Not applicable
30
Fuzhou
2023-08-17
Active, closed
Study of XGEVAยฎ (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone
NCT04586660Giant Cell Tumor of Bone
Amgen
Phase 4
36
Beijing, Fuzhou, Guangzhou, Harbin, Xi'an, Hangzhou
2023-08-17
Active, closed
AK112 in Combination With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer
NCT05840016Advanced Squamous Non Small Cell Lung Cancer
Akeso
Phase 3
532
Shanghai
2023-08-17
Recruiting
A Study of TY-2699a in Patients With Locally Advanced or Metastatic Solid Tumors
NCT05866692Solid Tumor, Adult
TYK Medicines, Inc
Phase 1
156
Beijing, Jinan
2023-08-17
Active, closed
Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)
NCT06577792Non Small Cell Lung Cancer
Sun Yat-sen University
Not applicable
620
Beijing, Fuzhou, Lanzhou, Dongguan, Foshan, Guangzhou, Wuhan, Nanjing
2023-08-16
Active, closed
A Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of Therapies
NCT05885555Primary Immune Thrombocytopenia (ITP)
Novartis Pharmaceuticals
Phase 2
41
Wuhan, Beijing, Jinan
2023-08-16
Recruiting
A Study of BA1202 in Patients With Advanced Solid Tumors
NCT05909241Advanced Solid Tumor
Shandong Boan Biotechnology Co., Ltd
Phase 1
78
Beijing
2023-08-16
Active, closed
FCN-338 in Combination With Azacitidine or Chemotherapy in Myeloid Neoplasms
NCT06858618Safety, Antitumor Activity, PK Profile
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 2
47
Wuhan
2023-08-16
Active, closed
A Study of GNC-035 in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematological Malignancies
NCT05944978Relapsed/Refractory Chronic Lymphocytic Leukemia
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1/2
3
Tianjin
2023-08-16
Recruiting
CD7 CAR-T in Adults With Relapsed or Refractory T-LBL/ALL Clinical Study
NCT06136364T-lymphoblastic Lymphoma, T-ALL
Hebei Senlang Biotechnology Inc., Ltd.
Phase 1
9
Shanghai
2023-08-15
Recruiting
Fluzoparib in Combination With Camrelizumab and Temozolomide in Advanced Melanoma
NCT05983237Melanoma
Jun Guo
Phase 1/2
50
Beijing
2023-08-15
Recruiting
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing
NCT06145308Salivary Gland Carcinoma, Precision Therapy
Peking Union Medical College
Phase 2
39
Beijing
2023-08-15
Not yet open
Organ Preservation Following Enverolimab-based Total Neoadjuvant Therapy for Locally Advanced Very Low Rectal Cancer
NCT05969847Rectal Cancer
ๆฑ ็•”
Phase 2
72
Fuzhou
2023-08-15
Recruiting
A Study of NBL-020 Injection in Subjects With Advanced Malignant Tumors.
NCT05877924Advanced Malignant Tumors
NovaRock Biotherapeutics, Ltd
Phase 1
200
Guanzhou
2023-08-15
Recruiting
Gene Therapy(FT-003) for Wet AMD
NCT06492863Neovascular Age-related Macular Degeneration
Frontera Therapeutics
Phase 1/2
78
Tianjin
2023-08-15
Not yet open
KN026 Plus Chemotherapy ยฑ KN-046 in HER2 Positive Colorectal Cancer and Biliary Carcinoma
NCT05985707HER2-positive Colorectal Cancer, HER2-positive Biliary Tract Cancer
Peking University Cancer Hospital & Institute
Phase 2
80
Beijing
2023-08-15
Recruiting
A Multi-center Clinical Longitudinal Study of Neuropathic Pain by Collecting Data
NCT06290024Pain
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
2,000
Shanghai
2023-08-15
Active, closed
Linperlisib in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma
NCT05949944Peripheral T-cell Lymphoma
Sun Yat-sen University
Phase 1/2
44
Guangzhou
2023-08-15
Active, closed
A Phase II/III Study of HR070803 in Combination With Oxaliplatin, 5-fluorouracil, Calcium Folinate and Bevacizumab Versus FOLFOX in Combination With Bevacizumab for First-line Treatment of Advanced Colorectal Cancer
NCT05945901Colorectal Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 2/3
669
Guangzhou
2023-08-14
Recruiting
A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd)-Based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With Primary Plasma Cell Leukemia
NCT05979363Plasma Cell Leukemia
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
20
Tianjin
2023-08-14
Active, closed
A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure
NCT05824923Pulmonary Hypertension, Heart Failure With Reduced Ejection Fraction, Hypertension, Vascular Diseases
Pulnovo Medical (Wuxi) Co., Ltd.
Phase 3
264
Shenyang
2023-08-14
Active, closed
Clinical Study of Allogeneic Fat Decellularized Active Protein in the Treatment of Pulmonary Fibrosis
NCT05883293Pulmonary Fibrosis
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase EARLY_PHASE1
7
Shanghai
2023-08-14
Recruiting
Universal CAR-T Cells (BRL-301) in Refractory Systemic Lupus Erythematosus
NCT05988216Systemic Lupus Erythematosus (SLE)
Bioray Laboratories
Not applicable
12
Hangzhou
2023-08-14
Active, closed
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years
NCT06041061HPV InfectioN, HPV-Related Carcinoma
Sinocelltech Ltd.
Phase 3
18,000
Nanning, Zhengzhou, Taiyuan, Chengdu, Kunming
2023-08-13
Recruiting
Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis
NCT05905172Liver Fibrosis
Beijing Continent Pharmaceutical Co, Ltd.
Phase 3
248
Beijing, Shanghai, Bengbu, Changsha, Chongqing, Guizhou, Hangzhou, Henan
2023-08-12
Active, closed
A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)
NCT05951725Diphtheria, Tetanus and Acellular Pertussis
CanSino Biologics Inc.
Phase 3
2,520
Xuchang
2023-08-11
Recruiting
A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors.
NCT06015048HER2-expressing Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
364
Hefei, Beijing, Chongqing, Nanning, Shijiazhuang, Harbin, Zhengzhou, Wuhan
2023-08-11
Recruiting
A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors
NCT06043466Colorectal Cancer, Esophagus Cancer, Gastric Cancer, Pancreas Cancer
Chongqing Precision Biotech Co., Ltd
Phase 1
30
Hangzhou
2023-08-11
Recruiting
SIRT for Potentially Resectable HCC
NCT05994859Hepatocellular Carcinoma
Second Affiliated Hospital of Guangzhou Medical University
Not applicable
35
Guangzhou
2023-08-10
Recruiting
Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent ฮฒ-thalassemia
NCT05776173ฮฒ-thalassemia Major
Shanghai BDgene Co., Ltd.
Not applicable
10
Shanghai
2023-08-10
Recruiting
Inhaled Nitric Oxide for High Amplitude Pulmonary Edema (HAPE)
NCT06852924High Altitude Pulmonary Hypertension
Novlead Inc.
Not applicable
100
Lhasa
2023-08-10
Active, closed
SRS for NSCLC With Oligo-residual Intracranial Disease After First-line 3rd Generation EGFR-TKI
NCT06020066Brain Metastases, Non-small Cell Lung Cancer
Fudan University
Phase 2
202
Shanghai
2023-08-10
Recruiting
A Real-world Study of the Efficacy and Safety of ICIs as First-line Therapy for Advanced Malignancies
NCT05862259Malignant Tumor, Immunotherapy, Artificial Intelligence
Xinqiao Hospital of Chongqing
Observational
120
Chongqing
2023-08-10
Recruiting
The Role of Extracellular DNA (ecDNA) in the Occurrence and Development of Gastric
NCT05956847Gastric Cancer, Precancerous Lesion of Digestive Tract, Extrachromosomal DNA
Xijing Hospital
Observational
1,000
Xi'an
2023-08-10
Recruiting
Exploring Cancer Evolution, Prognostic and Predictive Biomarkers in EGFR-mutant NSCLC
NCT05997719Non-small Cell Lung Cancer
Sun Yat-sen University
Observational
150
Guanzhou
2023-08-10
Rows per page Showing 14801–14900 of 19052
Previous 147 148 149 150 151 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=149

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.